MiSight® 1 day:
First and Only Soft Contact Lens FDA-Approved* to Slow the Progression of Myopia in Children 8-12 Years Old

OVERVIEW:

CooperVision’s MiSight® 1 day1 is the first and only contact lens approved by the FDA to slow the progression of myopia (ages 8-12 at the initiation of treatment)*. Children can insert the soft, daily wear, single use contact lenses in their eyes in the morning, wear them for at least 10 hours during the day, then dispose of them in the evening.

The FDA-approved* lens is available as part of a comprehensive myopia management approach offered by CooperVision and participating eye care practitioners.

HOW IT WORKS:

MiSight® 1 day is an award-winning2,3,4 dual-focus soft contact lens that uses ActivControlTechnology to slow the elongation of the eyeball. The ActivControlTechnology in MiSight® 1 day utilizes an optic zone concentric ring design with alternating vision correction and treatment zones. Two zones are vision correction zones with the label power of the contact lens, and the alternating two zones are treatment zones with 2 diopters of defocus to slow the progression of myopia.

This design allows the child to see clearly while benefiting from the treatment effect.

* Indications for Use: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.

CLINICALLY PROVEN – FIVE YEARS OF DATA:

CooperVision undertook a rigorous, multi-year, multi-country study to track how the MiSight® 1 day contact lens affected myopia progression when initially fit on children 8–12 years old. After three years, the study concluded the lens effectively slowed myopia progression by 59% and slowed the rate at which the eye lengthens by 52% compared to children in the control group wearing a single-vision 1-day lens.5 Results presented after the five-year mark continued to demonstrate safety and efficacy.

“After three years, the study concluded the lens effectively slowed myopia progression by 59% and slowed the rate at which the eye lengthens by 52% compared to children in the control group wearing a single-vision 1-day lens.”

EASE OF FITTING, WEAR, AND CARE:

Incorporating this technology into a 1-day disposable lens was based on the safety profile of lenses that are discarded after one day of use, as well as children’s ease of use and parental peace of mind. For children and parents, a multi-center study found:

90%
of children in the study preferred wearing MiSight® 1 day lenses over wearing eyeglasses.

90%
of children could apply and remove the MiSight® 1 day lenses on their own.

100%
of parents reported their children were happy with their experience wearing contact lenses. They noted the comfort, vision, ease of use, and freedom from eyeglasses as top benefits.

PROGRAM COSTS:

The cost of the program varies by region, but parents can expect costs to be similar to what they would pay for an orthodontics package.

When Children Can’t See Far:
A Discussion About Pediatric Myopia

DEFINING MYOPIA:

Myopia – often referred to as nearsightedness – is a common eye health condition in which the eyeball elongates, causing light rays to focus incorrectly in the eye, thus making distance vision blurry.

THE INCREASING PREVALENCE AND SEVERITY OF PEDIATRIC MYOPIA:

More than 40 percent of Americans are myopic and that number is increasing at an alarming rate, especially among school-aged children.

One in four parents have a child with myopia and about three quarters of children with myopia were diagnosed between the ages of 3 and 12.

Two-thirds of eye care professionals (ECPs) say the presence of myopia among children in their practice has increased over the past 5-10 years3, and 81% of ECPs recognize it as one of the biggest problems impacting children’s eyesight today.

CAUSES OF MYOPIA:

Myopia typically occurs during childhood when the eyeball develops a larger or longer shape, meaning the distance between the front of the eye and the retina at the back of the eye is longer than normal. Blurry vision due to myopia is the result of light rays focusing at a point in front of the retina rather than directly on the surface6.

However, the upward incidence of myopia can be attributed to different factors, and is occasionally the result of a combination of these factors:

Genetics – Family history plays a role in a child’s risk of myopia. If neither parent is myopic, the chance the child will develop myopia is low. But, if one parent is myopic, it increases the child’s chance of developing myopia by 3x – doubling to 6x if both parents are myopic

Environment – Exposure to sunlight, vitamin D intake, dopamine levels and the amount of time someone spends outdoors have an impact on an individual’s likelihood of being myopic. Research shows spending more time outdoors lowers the risk of childhood myopia.

MYOPIA LEVELS:

Though it may begin mildly, myopia may be progressive and may increase in severity from moderate to high myopia if treatment is delayed4. Each level of myopia is defined by a specific diopter (D) range. A diopter is the unit used to measure the correction, or focusing power, of the lens the eye requires.

LONG-TERM OCULAR HEALTH IMPACTS:

As the eye continues to grow and the amount of myopia increases, ocular tissues change in response to the eye growth, resulting in eye health risks that are not as evident in a non-myopic eye. The more nearsighted a child is, the greater these risks become8 and these risks increase exponentially as myopia progresses.

Leaving myopia untreated may contribute to more severe eye health complications later in life9, including:

Cataracts – a clouding of the lens of the eye that can cause changes in vision. Though cataracts can affect everyone as they age, they often develop sooner in those who are myopic.

Glaucoma – a condition, usually linked to high pressure inside the eye, that causes damage to the eye’s optic nerve, potentially causing irreversible vision loss and blindness. Studies show myopic people have a 2-3x greater risk of developing glaucoma.

Retinal detachment – occurs when the retina, a thin layer of tissue that surrounds the entire inside the eye, pulls away from supportive layers of blood vessels that provide its necessary oxygen and nourishment.

Macular Degeneration – caused by the deterioration of the central portion of the retina, and is a leading cause of severe, irreversible vision loss.

Leaving myopia untreated may contribute to more severe eye health complications later in life.

MANAGING MYOPIA:

The earlier myopia management starts, the better the outcomes regarding the child’s near- and long-term eye health. In the U.S., 71% of ECPs say it is absolutely essential to slow the progression of myopia among children ages 8 – 15 years old.

Managing myopia progression by even 1 diopter:

Reduces risk of myopic maculopathy by 40%
Reduces risk of open-angle glaucoma by 20%
Reduces risk of visual impairment by 20%
Saves between 0.5 and 0.9 years of visual impairment

Managing myopia starts with regular comprehensive eye exams so ECPs can determine progression and treatment.

CooperVision’s MiSight1 day13 is the first and only contact lens approved by the FDA* to slow the progression of myopia in children (8-12 years of age at the initiation of treatment). The FDA-approved* lens is available as part of a comprehensive myopia management approach offered by CooperVision and participating eye care practitioners.

To learn more about the MiSight1 day myopia management approach please visit www.coopervision.com.